GSK3B and cardiac hypertrophy: GSK-3β induces cardiac hypertrophy through the promotion of NFAT nuclear translocation; therefore, we confirmed that the TDZD-8 treatment induced the nuclear translocation of NFAT in Ang II-stimulated H9c2 cells (Figure 7).